Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Li Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2838-9807; OpenAlex author ID A5100336213. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. circular RNAs 0000515 and 0011385 as potential biomarkers for disease monitoring and determining prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2021.13174↗
  2. Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness. Co-author DOI 10.1038/s41598-017-06132-z↗
  3. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway. Co-author DOI 10.1186/s12943-017-0627-6↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yinkai Xue · 1 shared paper, 2022 · strength 0.22
  2. Han-Qing Wu · 1 shared paper, 2022 · strength 0.22
  3. Wei Zhou · 2 shared papers, 2017 · strength 0.14
  4. Heshui Wu · 2 shared papers, 2017 · strength 0.14
  5. Zhiyong Yang · 1 shared paper, 2017 · strength 0.08
  6. Tao Peng · 1 shared paper, 2017 · strength 0.08
  7. Chunyou Wang · 1 shared paper, 2017 · strength 0.08
  8. Tao Yin · 1 shared paper, 2017 · strength 0.06
  9. Tao Liu · 1 shared paper, 2017 · strength 0.06
  10. Ping Fan · 1 shared paper, 2017 · strength 0.06
  11. Shanmiao Gou · 1 shared paper, 2017 · strength 0.06
  12. Xin Jin · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.